Rheumatology Editing and Proofreading Services

Rheumatology manages conditions that last decades, with drugs that require monitoring and cost a great deal, for patients who often spent years being told nothing was wrong. Three writing problems follow from that. Disease activity has to be recorded in a way that shows a trajectory across years. Biologic funding has to be argued against criteria written by someone counting money. And patient material has to address people whose symptoms were disbelieved before they were diagnosed.

We edit what rheumatology services produce — consultation and referral letters, disease activity scoring and monitoring documentation, biologic and targeted therapy prior-authorisation letters and appeals, treat-to-target protocols, drug monitoring and safety documentation for methotrexate, biologics, and steroids, patient education on inflammatory arthritis, lupus, and connective tissue disease, pregnancy and fertility counselling material for patients on immunosuppression, infusion service documentation, shared care agreements with primary care, and manuscripts for rheumatology journals. Our editors check that the same disease activity measure is used consistently so the record shows a trend.

Biologic funding letters are the highest-value document here. Criteria are explicit and mechanical: a specific score, above a specific threshold, on a specific date, after documented failure of specific drugs at specific doses for specific durations. Letters that describe suffering eloquently but omit one of those elements are refused, and the refusal costs the patient months. We rebuild these letters around the criteria, in the criteria's own order, with the eloquence kept for the section where it helps.

Everything you send stays confidential. Whether you are appealing a refusal, standardising monitoring documentation across a shared care arrangement, or preparing a manuscript in English as an additional language, we can make the writing precise where precision unlocks treatment.